Background HLA-B27 is strongly associated with the development of spondyloarthritis (SPA), a disease characterized by new bone formation and ankylosis of joints and intervertebral spaces. We have recently shown the role of the two Wnt antagonists, dickkopf 1 (Dkk1) and sclerostin in new bone formation in SPA. We therefore hypothesized that HLA-B27 itself may be associated with alterations in expression of Dkk1 and sclerostin.
Objectives To test whether positivity for HLA-B27 per se is associated with changes of biomarkers of the Wnt pathway.
Methods Sera of 31 patients with HLA-B27 positive SPA, 30 patients with HLA-B27 positive uveitis, 30 healthy carriers of HLA-B27 as well as 90 age and gender matched HLA-B27 negative healthy controls were examined for total Dkk1 and sclerostin levels by enzyme-linked immunosorbent assays (ELISA). Statistical analysis was done by one-way analysis of variance (ANOVA).
Results Healthy HLA-B27 positive individuals showed significant lower levels of Dkk-1 compared with the negative controls (p=0.01). Moreover, Dkk1 levels were reduced in all three HLA-B27 positive groups, even in healthy HLA-B27 carriers. Additionally, serum levels of sclerostin were higher in HLA-B27 negative controls than in SPA HLA-B27 carriers.
Conclusions HLA-B27 positivity is associated with low levels of Dkk1 and sclerostin independent from the presence of clinical symptoms of SPA. Both HLA-B27 healthy carriers as well as HLA-B27 associated uveitis without SPA show lower levels of these two Wnt antagonists than normal HLA-B27 negative controls. These data suggest that alterations in bone metabolism even occur in the absence of clinical SPA and are associated with HLA-B27 carriage.
Disclosure of Interest None Declared
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.